Physiomics Awarded Multiple Contract Awards

AI SummaryClose X

Physiomics plc has announced the award of multiple new contracts this month with a combined value exceeding £345,000, including engagements with UK and international biotechnology and oncology-focused organisations, and a NASDAQ-listed company. These projects, which will leverage the company's expertise in modelling, simulation, biometrics, and data science, are expected to generate revenue through to the end of 2027, supporting key stages of drug development such as Phase 1 and 2 data analysis and dose selection. The company views these contract wins as a demonstration of its growing client relationships and scientific reputation.

Disclaimer*

Companies

Physiomics (PYC)
UK 100

Latest directors dealings